Cue Biopharma CUE
NASDAQ CUE
$18.66 -0.23 (-1.22%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Amortization of Deferred Charges (2020 - 2025)

Updated

Analysis

Cue Biopharma (CUE) Amortization of Deferred Charges (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Cue Biopharma 117.65 Mn 26.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -30,000.00
Sep 30, 2025 9,000.00
Jun 30, 2025 9,000.00
Mar 31, 2025 9,000.00
Dec 31, 2024 9,000.00
Sep 30, 2024 9,000.00
Jun 30, 2024 9,000.00
Mar 31, 2024 9,000.00
Sep 30, 2023 9,000.00
Jun 30, 2023 9,000.00
Mar 31, 2023 -149,000.00
Dec 31, 2022 -220,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 9,000.00
Mar 31, 2022 3,000.00
Dec 31, 2021 419.00
Mar 31, 2021 -5,000.00
Dec 31, 2020 6,694.00
Sep 30, 2020 22,000.00
API Access

Cue Biopharma Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CUE&period=max&api_key=YOUR_API_KEY